Literature DB >> 21537962

Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.

Giovanni Barbara1, Cesare Cremon, Roberto De Giorgio, Giovanni Dothel, Lisa Zecchi, Lara Bellacosa, Giovanni Carini, Vincenzo Stanghellini, Roberto Corinaldesi.   

Abstract

Visceral hypersensitivity is currently considered a key pathophysiological mechanism involved in pain perception in large subgroups of patients with functional gastrointestinal disorders, including irritable bowel syndrome (IBS). In IBS, visceral hypersensitivity has been described in 20%-90% of patients. The contribution of the central nervous system and psychological factors to visceral hypersensitivity in patients with IBS may be significant, although still debated. Peripheral factors have gained increasing attention following the recognition that infectious enteritis may trigger the development of persistent IBS symptoms, and the identification of mucosal immune, neural, endocrine, microbiological, and intestinal permeability abnormalities. Growing evidence suggests that these factors play an important role in pain transmission from the periphery to the brain via sensory nerve pathways in large subsets of patients with IBS. In this review, we will report on recent data on mechanisms involved in visceral hypersensitivity in IBS, with particular attention paid to peripheral mechanisms.

Entities:  

Mesh:

Year:  2011        PMID: 21537962     DOI: 10.1007/s11894-011-0195-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  98 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Marroon Thabane; Alexandre Belisle; Geneviève Geneau; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins; Denis Franchimont; John K Marshall
Journal:  Gastroenterology       Date:  2010-01-04       Impact factor: 22.682

3.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

4.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?

Authors:  Cesare Cremon; Giovanni Carini; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Corinaldesi; Giovanni Barbara
Journal:  Expert Rev Mol Diagn       Date:  2010-05       Impact factor: 5.225

6.  Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli.

Authors:  Sigrid Elsenbruch; Christina Rosenberger; Ulrike Bingel; Michael Forsting; Manfred Schedlowski; Elke R Gizewski
Journal:  Gastroenterology       Date:  2010-06-22       Impact factor: 22.682

7.  Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

Authors:  Cesare Cremon; Luciana Gargano; Antonio M Morselli-Labate; Donatella Santini; Rosanna F Cogliandro; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Corinaldesi; Giovanni Barbara
Journal:  Am J Gastroenterol       Date:  2009-01-13       Impact factor: 10.864

8.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 9.  Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.

Authors:  Pierangelo Geppetti; Marcello Trevisani
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

Review 10.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more
  43 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

Review 2.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Sai-Yue Liu; Qin-Qin Yang; Tang-Biao Shen
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Colonic butyrate- algesic or analgesic?

Authors:  P Kannampalli; R Shaker; J N Sengupta
Journal:  Neurogastroenterol Motil       Date:  2011-11       Impact factor: 3.598

Review 5.  Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.

Authors:  Vassilia Theodorou; Afifa Ait Belgnaoui; Simona Agostini; Helene Eutamene
Journal:  Gut Microbes       Date:  2014 May-Jun

Review 6.  [Neurobiology of visceral pain].

Authors:  W Jänig
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

7.  Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.

Authors:  Hannah Ceuleers; Nikita Hanning; Jelena Heirbaut; Samuel Van Remoortel; Jurgen Joossens; Pieter Van Der Veken; Sven M Francque; Michelle De Bruyn; Anne-Marie Lambeir; Joris G De Man; Jean-Pierre Timmermans; Koen Augustyns; Ingrid De Meester; Benedicte Y De Winter
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

8.  Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.

Authors:  Feng-Yan Yu; Shao-Gang Huang; Hai-Yan Zhang; Hua Ye; Hong-Gang Chi; Ying Zou; Ru-Xi Lv; Xue-Bao Zheng
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 9.  Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-04

10.  P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.

Authors:  Yumei Luo; Cheng Feng; Jing Wu; Yongxing Wu; Dong Liu; Jie Wu; Fei Dai; Jun Zhang
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.